Hua Jiang

Partnering with external collaborators, we dedicate our work to developing of innovative medicines for our patients all of the world. Covering multiple therapeutic areas, including Women's health, Gastro, Cardiometabolic, CNS and pediatric drugs, we engage the external partners to collaborate with Abbott medcine to utilize new science and technology to enhance the drug quality and efficacy.

Part of the international team 'Research Beyond Borders' Search for and manage adamic collaboration research projects Scouting for early stage biotech asset opportunities in China Focusing on emerging therapeutic fields and innovative technologies

Project leader of drug discovery project at research stage, covering target validation, SAR assay and hits-to-lead optimization, in vivo disease modeling, PK/PD & pre-clinical efficacy research.

Drug Discovery & Biomedical Research 1) Phenotypic assay development for compound screening on epigenetic targets. 2) High-Content Screening (HCS) platform management, Cellomics and Acumen. 3) Target validation and compound hunting for hearing regeneration project. 4) Development of ex vivo tissue culture models to evaluate the efficacy of drug candidates

ES/iPS cell line establishment, characterization, and directed differentiation of mouse and human embryonic stem cells to neural precursor cell and neuron. Education

Lab. of Stem Cells Research, Institute of Health Sciences. SIBS

Learn and apply key principles of roadmapping as an efficient approach for product and technology strategy.